Common use of Testing for Controlled Substances Clause in Contracts

Testing for Controlled Substances. The Employer has established its anti-drug program through this Policy and strictly prohibits the unlawful manufacture, distribution, dispensing, possession or unauthorized use of a controlled substance in the workplace. Further, any abnormal conduct that may create a reasonable suspicion that an employee is under the influence of a controlled substance is addressed in the Reasonable Suspicion Testing section described previously in this Policy. For purposes of this Policy, the employer shall test for the following controlled substances. Concentrations of controlled substances at or above the following levels shall be considered positive and confirmation test results as follows: Type of Drug or Metabolite Initial Test Confirmation Test Marijuana metabolites ▇▇▇▇▇-▇-▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇- ▇▇ ▇▇ 9-carboxylic acid (THC) Cocaine 300 150 metabolites (Benzoylecgoine) Phencyclidine (PCP) 25 25 Amphetamines 1000 Amphetamine 500 Methamphetamine 500 (Specimen must also contain amphetamine at a concentration of greater than or equal to 200 ng/mL. Opiate metabolites 2000 Codeine 2000 Morphine 2000 6-acetylmorphine (6-AM) 10 (Test for 6-AM in the specimen. Conduct this test only when specimen contains morphine at a concentration greater than or equal to 2000 ng/mL.) The drug screen panel is subject to modification as required by the Federal Regulations referenced above. Drug testing is conducted by analyzing an employee’s urine specimen (through a certified testing lab). This procedure includes the use of a split specimen testing procedure. Each urine specimen is subdivided into two bottles labeled as a "primary" and a "split" specimen. Both bottles will be sent to a certified lab. Only the "primary" specimen is opened and used for the urinalysis. The split specimen bottle will remain sealed and stored at the lab. If the analysis of the primary specimen confirms the presence of illegal, controlled substance, the employee has 72 hours to request the split specimen be retested at the same lab or b sent to another certified laboratory for analysis. An employee, who fails to notify the Medical Review Officer within 72 hours of receiving the results of the positive test of the employee’s desire to have the split specimen tested shall be deemed to have waived the employee’s right to seek testing of the split specimen. In some cases, the employee may be unable to provide a urine sample. After a reasonable waiting period (not more than two hours) the collection site person may terminate the testing procedure.

Testing for Controlled Substances. The Employer has established its anti-drug program through this Policy and strictly prohibits the unlawful manufacture, distribution, dispensing, possession or unauthorized use of a controlled substance in the workplace. Further, any abnormal conduct that may create a reasonable suspicion that an employee is under the influence of a controlled substance is addressed in the Reasonable Suspicion Testing section described previously in this Policy. For purposes of this Policy, the employer shall test for the following concentrations of alcohol or controlled substances. , which shall be considered a positive test when using an EMT immunoassay drug screening test: Alcohol 0.04% Amphetamines 1000 ng/ml Barbiturates 200 ng/ml Cocaine 300 ng/ml Opiates 300 ng/ml THC 100 ng/ml PCP 25 ng/ml Benzodiazepines 200 ng/ml Methadone 300 ng/ml Concentrations of alcohol or controlled substances at or above the following levels shall be considered a positive and confirmation test results as followsresult when performing a confirmatory GC/MS test on a urine specimen tested positive using a technological different initial screening method. Alcohol 0.04% Marijuana Metabolite* 15 Cocaine Metabolite** 150 Opiates Morphine*** 300 Codeine 300 Phencyclidine 25 Amphetamines: Type of Drug or Metabolite Initial Test Confirmation Test Marijuana metabolites ▇▇▇▇▇-▇-▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇- ▇▇ ▇▇ 9-carboxylic acid (THC) Cocaine 300 150 metabolites (Benzoylecgoine) Phencyclidine (PCP) 25 25 Amphetamines 1000 Amphetamine 500 Methamphetamine 500 (Specimen must also contain amphetamine at a concentration of greater than or equal to 200 *Delta-9 tetrhydrocannabinol -9- carboxylic acid **Benzolyecgonine ***25 ng/mL. Opiate metabolites 2000 Codeine 2000 Morphine 2000 6ml if immunoassay-acetylmorphine (6-AM) 10 (Test specific for 6-AM in the specimen. Conduct this test only when specimen contains free morphine at a concentration greater than or equal to 2000 ng/mL.) The drug screen panel is subject to modification as required by the Federal Regulations referenced above. Drug testing is conducted by analyzing an employee’s urine specimen (through a certified testing lab). This procedure includes the use of a split specimen testing procedure. Each urine specimen is subdivided into two bottles labeled as a "“primary" ” and a "“split" ” specimen. Both bottles will be sent to a certified lab. Only the "“primary" ” specimen is opened and used for the urinalysis. The split specimen bottle will remain sealed and stored at the lab. If the analysis of the primary specimen confirms the presence of illegal, controlled substance, the employee has 72 hours to request the split specimen be retested at the same lab or b be sent to another certified laboratory for analysis. An employee, who fails to notify the Medical Review Officer within 72 hours of receiving the results of the positive test of the employee’s desire to have the split specimen tested shall be deemed to have waived the employee’s right to seek testing of the split specimen. In some cases, the employee may be unable to provide a urine sample. After a reasonable waiting period (not more than two hours) the collection site person may terminate the testing procedure.